Author

Peter Hegyi

FATTY PANCREAS IS A RISK FACTOR FOR PANCREATIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 2,956 PATIENTS
FATTY PANCREAS IS A RISK FACTOR FOR PANCREATIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 2,956 PATIENTS

Peter Hegyi  et al.

COMMON CASR VARIANTS IN HUNGARIAN CHRONIC PANCREATITIS PATIENTS
COMMON CASR VARIANTS IN HUNGARIAN CHRONIC PANCREATITIS PATIENTS

Peter Hegyi  et al.

DISTINCT EFFECT OF ANTI-TUMOR NECROSIS FACTOR-ALFA AND CONVENTIONAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND META-ANALYSIS
DISTINCT EFFECT OF ANTI-TUMOR NECROSIS FACTOR-ALFA AND CONVENTIONAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VENOUS THROMBOEMBOLISM: SYSTEMATIC REVIEW AND META-ANALYSIS

Peter Hegyi  et al.

INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS
INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS

Peter Hegyi  et al.

COMMON CASR POLYMORPHISMS DO NOT INCREASE CHRONIC PANCREATITIS RISK
COMMON CASR POLYMORPHISMS DO NOT INCREASE CHRONIC PANCREATITIS RISK

Peter Hegyi  et al.

THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PANCREATIC DUCTAL EPITHELIAL CELLS UNDER PATHOPHYSOLOGICAL CONDITIONS
THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PANCREATIC DUCTAL EPITHELIAL CELLS UNDER PATHOPHYSOLOGICAL CONDITIONS

Peter Hegyi  et al.

SEVERITY OF ACUTE PANCREATITIS IS GREATLY ASSOCIATED WITH THE RISK OF DEVELOPING NEW-ONSET DIABETES OR DYSGLYCAEMIA AFTER INFLAMMATION: A META-ANALYSIS OF 72,813 PATIENTS
SEVERITY OF ACUTE PANCREATITIS IS GREATLY ASSOCIATED WITH THE RISK OF DEVELOPING NEW-ONSET DIABETES OR DYSGLYCAEMIA AFTER INFLAMMATION: A META-ANALYSIS OF 72,813 PATIENTS

Peter Hegyi  et al.

SYSTEMATIC REVIEW AND META-ANALYSIS: MICROSCOPIC COLITIS IS A RISK FACTOR FOR LOW BONE DENSITY
SYSTEMATIC REVIEW AND META-ANALYSIS: MICROSCOPIC COLITIS IS A RISK FACTOR FOR LOW BONE DENSITY

Peter Hegyi  et al.

ANTICOAGULANTS DECREASE MORTALITY AND MAJOR COMPLICATION RATES IN MODERATELY SEVERE AND SEVERE ACUTE PANCREATITIS – A SYSTEMATIC REVIEW AND META-ANALYSIS
ANTICOAGULANTS DECREASE MORTALITY AND MAJOR COMPLICATION RATES IN MODERATELY SEVERE AND SEVERE ACUTE PANCREATITIS – A SYSTEMATIC REVIEW AND META-ANALYSIS

Peter Hegyi  et al.

CHARACTERIZATION OF HCO3 SECRETION IN HUMAN PANCREATIC DUCTAL ORGANOID CULTURES
CHARACTERIZATION OF HCO3 SECRETION IN HUMAN PANCREATIC DUCTAL ORGANOID CULTURES

Peter Hegyi  et al.

CELL-FREE DNA BIOMARKERS PREDICT OVERALL AND PROGRESSION-FREE SURVIVAL IN PANCREATIC ADENOCARCINOMA – A SYSTEMATIC REVIEW AND META-ANALYSIS
CELL-FREE DNA BIOMARKERS PREDICT OVERALL AND PROGRESSION-FREE SURVIVAL IN PANCREATIC ADENOCARCINOMA – A SYSTEMATIC REVIEW AND META-ANALYSIS

Peter Hegyi  et al.

EVIDENCE FOR DIAGNOSIS OF EARLY CHRONIC PANCREATITIS AFTER THREE EPISODES OF ACUTE PANCREATITIS
EVIDENCE FOR DIAGNOSIS OF EARLY CHRONIC PANCREATITIS AFTER THREE EPISODES OF ACUTE PANCREATITIS

Peter Hegyi  et al.

OPTIMAL THRESHOLD FOR RESTRICTIVE TRANSFUSION AFTER ACUTE GASTROINTESTINAL BLEEDING: INSIGHTS FROM THE HUNGARIAN GASTROINTESTINAL BLEEDING REGISTRY
OPTIMAL THRESHOLD FOR RESTRICTIVE TRANSFUSION AFTER ACUTE GASTROINTESTINAL BLEEDING: INSIGHTS FROM THE HUNGARIAN GASTROINTESTINAL BLEEDING REGISTRY

Peter Hegyi  et al.

TIME DEPENDENCY AND RISK FACTORS OF SPLANCHNIC VEIN THROMBOSIS DEVELOPMENT IN THE EARLY PHASE OF ACUTE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
TIME DEPENDENCY AND RISK FACTORS OF SPLANCHNIC VEIN THROMBOSIS DEVELOPMENT IN THE EARLY PHASE OF ACUTE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Peter Hegyi  et al.

RISK FACTORS FOR DIABETES MELLITUS AFTER ACUTE PANCREATITIS:A SYSTEMATIC REVIEW AND META-ANALYSIS
RISK FACTORS FOR DIABETES MELLITUS AFTER ACUTE PANCREATITIS:A SYSTEMATIC REVIEW AND META-ANALYSIS

Peter Hegyi  et al.

PSYCHOLOGICAL INTERVENTIONS IMPROVE OUTCOMES IN INFLAMMATORY DIGESTIVE SYSTEM DISEASES. A META-ANALYSIS
PSYCHOLOGICAL INTERVENTIONS IMPROVE OUTCOMES IN INFLAMMATORY DIGESTIVE SYSTEM DISEASES. A META-ANALYSIS

Peter Hegyi  et al.

EARLY PHASE OF CHRONIC PANCREATITIS: RESULTS OF A 2-YEAR FOLLOW-UP OF THE FIRST 133 PATIENTS OF THE GOULASH-PLUS CLINICAL TRIAL
EARLY PHASE OF CHRONIC PANCREATITIS: RESULTS OF A 2-YEAR FOLLOW-UP OF THE FIRST 133 PATIENTS OF THE GOULASH-PLUS CLINICAL TRIAL

Peter Hegyi  et al.

RECURRENT ACUTE PANCREATITIS PREVENTION BY THE ELIMINATION OF ALCOHOL AND CIGARETTE SMOKING (REAPPEAR): PROTOCOL OF A RANDOMIZED CONTROLLED TRIAL AND A COHORT STUDY
RECURRENT ACUTE PANCREATITIS PREVENTION BY THE ELIMINATION OF ALCOHOL AND CIGARETTE SMOKING (REAPPEAR): PROTOCOL OF A RANDOMIZED CONTROLLED TRIAL AND A COHORT STUDY

Peter Hegyi  et al.

A 2-YEAR FOLLOW-UP OF ACUTE PANCREATITIS: PRELIMINARY RESULTS OF THE GOULASH-PLUS STUDY OF ENDOCRINE AND EXOCRINE INSUFFICIENCY
A 2-YEAR FOLLOW-UP OF ACUTE PANCREATITIS: PRELIMINARY RESULTS OF THE GOULASH-PLUS STUDY OF ENDOCRINE AND EXOCRINE INSUFFICIENCY

Peter Hegyi  et al.

CEL-HYB1 HAPLOTYPES CONFER VARYING RISK FOR CHRONIC PANCREATITIS
CEL-HYB1 HAPLOTYPES CONFER VARYING RISK FOR CHRONIC PANCREATITIS

Peter Hegyi  et al.

Item 61 - 80 / 90
1 2 3
4
5